January 21, 2015
The 2015 American Society of Cancer Oncology (ASCO) Gastrointestinal Cancers Symposium held in San Francisco was the site of a presentation on January 12, 2015 concerning the finding of longer average survival among colorectal cancer patients with higher vitamin D levels in comparison with those whose levels were low. Researchers at Dana-Farber Cancer Institute analyzed data from 1,043 patients with colorectal cancer enrolled in a clinical trial that evaluted the effects chemotherapy plus the biologic therapies bevacizumab and/or cetuximab. Plasma 25-hydroxyvitamin D levels were measured at the beginning of the study and dietary questionnaire responses were analyzed for vitamin D intake from […]

